← Scroll for more →
Foxo Technologies Inc. (FOXO)
Services-Commercial Physical & Biological Research
Latest Price
$0.09
Market Cap
$152,878
TTM P/E
--
Earnings Yield
--
TTM Div Yield
--
P/B Ratio
--
Price at the 2025-08-12 close. Earnings yield is trailing 12-month earnings divided by price.
Price
full chart →- 1-Year Change
- -96.44%
- 52-Week High
- $25.87
- 52-Week Low
- $0.09
Daily close, 2024-08-12 to 2025-08-12
Financials
financial statements →| Quarter ending | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Last 4 quarters |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10,000 | $110,000 | $7,000 | $28,000 | $1.20M | $2.82M | $3.17M | $5.22M | $3.55M | $4.43M | $5.17M | $4.72M | $17.86M |
| Gross margin | -600.0% | 43.6% | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating margin | -35070.0% | -3349.1% | -16842.9% | -5675.0% | -84.0% | -141.4% | -48.8% | 10.9% | -24.2% | -191.6% | -5.4% | 185.5% | -4.9% |
| Net income | -$3.66M | -$3.86M | -$1.50M | -$2.16M | -$1.95M | -$6.79M | -$616,458 | -$522,021 | -$1.88M | -$9.42M | -$1.45M | $8.14M | -$4.60M |
| Net margin | -36600.0% | -3508.2% | -21485.7% | -7725.0% | -162.7% | -240.8% | -19.4% | -10.0% | -52.9% | -212.5% | -28.1% | 172.6% | -25.8% |
| Operating cash flow | -$865,000 | -$480,000 | $1.72M | -$1.17M | -$1.55M | -$1.85M | -$1.34M | -$2.38M | -$44,784 | -$104,030 | -$577,898 | $298,674 | -$428,038 |
| Free cash flow | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -$581,893 | $293,295 | -- |
Chart: revenue per quarter, Sep 2023 to Jun 2026. Hover over or tap a row to chart it.
Capital Structure
balance sheet →- Shares Outstanding
- 1.66M
- Total Debt
- --
- Long-term Debt
- --
- Long-term Debt / Capital
- --
- Cash
- $58,409
- Current Assets
- $4.76M
- Current Liabilities
- $40.62M
Current position as of 2026-06-30.
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 19.2K | -- | 1.16% | -- | 2025-06-30 |
Recent Material Events
all events →- FOXO Technologies Inc. entered into agreements to acquire approximately 71.43% of Ludwig Enterprises, Inc.'s preferred stock from The Thomas E. Terwilliger Revocable Trust and Vasaio Capital, Inc., securing majority voting control. In exchange for 5,000,000 shares of Ludwig preferred stock, FOXO will issue 2,250,000 shares of new Series F Convertible Preferred Stock with a stated value of $2,250,000. Additionally, FOXO agreed to purchase approximately $1,000,000 in notes from Thomas E. Terwilliger for $1,000,000 in consideration comprising cash and Series F shares. The transactions are pending closing conditions including a Nasdaq listing and financing. FOXO operates hospitals, behavioral health facilities, and biotechnology subsidiaries.